Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Transplantation

  Free Subscription


Articles published in Transplantation

Retrieve available abstracts of 214 articles:
HTML format
Text format



Single Articles


    April 2017
  1. NEUBERGER JM, Bechstein WO, Kuypers DR, Burra P, et al
    Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group.
    Transplantation. 2017;101.
    PubMed     Text format     Abstract available


    March 2017
  2. SHENG M, Lin Y, Weng Y, Xu R, et al
    Predictive Value of Intraoperative Troponin I Elevation in Pediatric Living Donor Liver Transplant Recipients With Biliary Atresia.
    Transplantation. 2017 Mar 18. doi: 10.1097/TP.0000000000001732.
    PubMed     Text format     Abstract available


  3. PARLAK E, Koksal AS, Eminler AT, Toka B, et al
    Treatment of Biliary Stricture After Live Donor Liver Transplantation With Combined Metal and Plastic Stent Insertion: A Feasibility and Safety Study.
    Transplantation. 2017 Mar 18. doi: 10.1097/TP.0000000000001734.
    PubMed     Text format     Abstract available


  4. NEKRASOV V, Matsuoka L, Kaur N, Pita A, et al
    Improvement in the Outcomes of MELD >/= 40 Liver Transplantation: An Analysis of 207 Consecutive Transplants in a Highly Competitive DSA.
    Transplantation. 2017 Mar 18. doi: 10.1097/TP.0000000000001738.
    PubMed     Text format     Abstract available


  5. KONERMAN MA, Fritze D, Weinberg RL, Sonnenday CJ, et al
    Incidence of and Risk Assessment for Adverse Cardiovascular Outcomes Following Liver Transplantation: A Systematic Review.
    Transplantation. 2017 Mar 15. doi: 10.1097/TP.0000000000001710.
    PubMed     Text format     Abstract available


  6. BHATI C, Idowu MO, Sanyal AJ, Rivera M, et al
    Long Term Outcomes in Patients Undergoing Liver Transplantation for Nonalcoholic Steatohepatitis Related Cirrhosis.
    Transplantation. 2017 Mar 15. doi: 10.1097/TP.0000000000001709.
    PubMed     Text format     Abstract available


  7. MURALI AR, Patil S, Phillips KT, Voigt M, et al
    Locoregional Therapy with Curative Intent versus Primary Liver Transplant for Hepatocellular Carcinoma: Systematic Review and Meta-analysis.
    Transplantation. 2017 Mar 10. doi: 10.1097/TP.0000000000001730.
    PubMed     Text format     Abstract available


  8. MOUCHLI MA, Singh S, Loftus EV Jr, Boardman L, et al
    Risk Factors and Outcomes of De novo Cancers (Excluding Nonmelanoma Skin Cancer) after Liver Transplantation for Primary Sclerosing Cholangitis.
    Transplantation. 2017 Mar 8. doi: 10.1097/TP.0000000000001725.
    PubMed     Text format     Abstract available


  9. AULBERT W, Kobbe R, Breuer C, Briem-Richter A, et al
    Hypereosinophilic Syndrome After Liver Transplantation - a Case Report and a Review of the Literature.
    Transplantation. 2017 Mar 4. doi: 10.1097/TP.0000000000001721.
    PubMed     Text format     Abstract available


  10. SIMONETTA F, Pradier A, Masouridi-Levrat S, van Delden C, et al
    Torque Teno Virus Load and Acute Rejection after Orthotopic Liver Transplantation.
    Transplantation. 2017 Mar 4. doi: 10.1097/TP.0000000000001723.
    PubMed     Text format    


  11. LAI Q, Feys E, Karam V, Adam R, et al
    Hepatic Epithelioid Hemangioendothelioma and Adult Liver Transplantation: Proposal for a Prognostic Score Based on the Analysis of the ELTR-ELITA Registry.
    Transplantation. 2017;101:555-564.
    PubMed     Text format     Abstract available


  12. TERRAULT N, Berenguer M, Strasser S, Gadano A, et al
    International Liver Transplant Society Consensus Statement on HEPATITIS C MANAGEMENT IN LIVER TRANSPLANT RECIPIENTS.
    Transplantation. 2017 Mar 1. doi: 10.1097/TP.0000000000001704.
    PubMed     Text format    


  13. TERRAULT NA, McCaughan GW, Curry MP, Gane E, et al
    International Liver Transplant Society Consensus Statement on HEPATITIS C MANAGEMENT IN LIVER TRANSPLANT CANDIDATES.
    Transplantation. 2017 Mar 1. doi: 10.1097/TP.0000000000001708.
    PubMed     Text format    


  14. ARONSOHN A
    Timing is Everything: Managing Hepatitis C in Liver Transplant Candidates.
    Transplantation. 2017 Mar 1. doi: 10.1097/TP.0000000000001703.
    PubMed     Text format    


    February 2017
  15. BRUINSMA BG, Avruch JH, Sridharan GV, Weeder PD, et al
    Peritransplant energy changes and their correlation to outcome after human liver transplantation.
    Transplantation. 2017 Feb 23. doi: 10.1097/TP.0000000000001699.
    PubMed     Text format     Abstract available


  16. EBEL NH, Hsu EK, Berry K, Horslen SP, et al
    Disparities in waitlist and posttransplantation outcomes in liver transplant registrants and recipients 18-24 years old: analysis of the UNOS database.
    Transplantation. 2017 Feb 22. doi: 10.1097/TP.0000000000001689.
    PubMed     Text format     Abstract available


  17. VERNA EC, Brown RS Jr
    HCV Antiviral Therapy In Liver Transplant Candidates and Recipients with Renal Insufficiency.
    Transplantation. 2017 Feb 16. doi: 10.1097/TP.0000000000001688.
    PubMed     Text format     Abstract available


  18. XIE Y, Wu Y, Xin K, Wang JJ, et al
    Delayed Donor Bone Marrow Infusion Induces Liver Transplant Tolerance.
    Transplantation. 2017 Feb 10. doi: 10.1097/TP.0000000000001684.
    PubMed     Text format     Abstract available


  19. BADENOCH A, Sharma A, Gower S, Selzner M, et al
    The Effectiveness and Safety of Tranexamic Acid in Orthotopic Liver Transplantation Clinical Practice: A Propensity Score Matched Cohort Study.
    Transplantation. 2017 Feb 10. doi: 10.1097/TP.0000000000001682.
    PubMed     Text format     Abstract available


  20. WADSTROM J, Ericzon BG, Halloran PF, Bechstein WO, et al
    Advancing Transplantation: New Questions, New Possibilities in Kidney and Liver Transplantation.
    Transplantation. 2017;101 Suppl 2S:S1-S41.
    PubMed     Text format    


  21. CHAPMAN WC, Brown RS Jr, Chavin KD, Sudan D, et al
    Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation.
    Transplantation. 2017;101:341-349.
    PubMed     Text format     Abstract available


  22. LERUT J
    Jan Lerut, MD, PhD: Professor Emeritus of Surgery, Director of the Starzl Abdominal Transplant Unit, University Hospitals Saint Luc and UCL Transplant Centre in Brussels; and Past President, European Society of Organ Transplantation and International
    Transplantation. 2017;101:223-226.
    PubMed     Text format    


    January 2017
  23. GOLDBERG DS, Karp SJ, McCauley ME, Markmann JF, et al
    Interpreting Outcomes in DCDD Liver Transplantation: First Report of the Multi-Center IDOL Consortium.
    Transplantation. 2017 Jan 21. doi: 10.1097/TP.0000000000001656.
    PubMed     Text format     Abstract available


  24. SATAPATHY SK, Vanatta JM, Helmick R, Flowers A, et al
    Outcome of Liver Transplant Recipients With Revascularized Coronary Artery Disease: A Comparative Analysis With and Without Cardiovascular Risk Factors.
    Transplantation. 2017 Jan 17. doi: 10.1097/TP.0000000000001647.
    PubMed     Text format     Abstract available


  25. KIM KH, Kang SH, Jung DH, Yoon YI, et al
    Initial outcomes of pure laparoscopic living donor right hepatectomy in an experienced adult living donor liver transplant center.
    Transplantation. 2017 Jan 9. doi: 10.1097/TP.0000000000001637.
    PubMed     Text format     Abstract available


  26. VINAIXA C, Strasser SI, Berenguer M
    DISEASE REVERSIBILITY IN PATIENTS WITH POSTHEPATITIS C CIRRHOSIS: IS THE POINT OF NO RETURN THE SAME BEFORE AND AFTER LIVER TRANSPLANTATION? A REVIEW.
    Transplantation. 2017 Jan 6. doi: 10.1097/TP.0000000000001633.
    PubMed     Text format     Abstract available



  27. Adherence to and Acceptance of Once-Daily Tacrolimus After Kidney and Liver Transplant: Results From OSIRIS, a French Observational Study: Erratum.
    Transplantation. 2017;101:e40-e41.
    PubMed     Text format    



  28. Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation: Erratum.
    Transplantation. 2017;101:e40.
    PubMed     Text format    


  29. LIU D, Chan AC, Fong DY, Lo CM, et al
    Evidence-Based Surveillance Imaging Schedule After Liver Transplantation for Hepatocellular Carcinoma Recurrence.
    Transplantation. 2017;101:107-111.
    PubMed     Text format     Abstract available


  30. DEMARTINO ES, Cartin-Ceba R, Findlay JY, Heimbach JK, et al
    Frequency and Outcomes of Patients With Increased Mean Pulmonary Artery Pressure at the Time of Liver Transplantation.
    Transplantation. 2017;101:101-106.
    PubMed     Text format     Abstract available


  31. ONO Y, Perez-Gutierrez A, Yovchev MI, Matsubara K, et al
    Regeneration and Cell Recruitment in an Improved Heterotopic Auxiliary Partial Liver Transplantation Model in the Rat.
    Transplantation. 2017;101:92-100.
    PubMed     Text format     Abstract available


    December 2016
  32. FREIRE MP, Oshiro IC, Pierrotti LC, Bonazzi PR, et al
    Carbapenem-Resistant Enterobacteriaceae Acquired before Liver Transplantation: Impact on Recipient Outcomes.
    Transplantation. 2016 Dec 22. doi: 10.1097/TP.0000000000001620.
    PubMed     Text format     Abstract available


  33. DIAZ GC, Zerillo J, Singhal A, Hibi T, et al
    Report of the 22nd Annual Congress of the International Liver Transplantation Society.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  34. KIM PT, Fernandez H, Gupta A, Saracino G, et al
    Low measured hepatic artery flow increases rate of biliary strictures in deceased donor liver transplantation: An age dependent phenomenon.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  35. LAU L, Kankanige Y, Rubinstein B, Jones R, et al
    Machine-Learning Algorithms Predict Graft Failure Following Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  36. HAMAGUCHI Y, Kaido T, Okumura S, Kobayashi A, et al
    Impact of skeletal muscle mass index, intramuscular adipose tissue content, and visceral to subcutaneous adipose tissue area ratio on early mortality of living donor liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  37. LAI Q, Feys E, Karam V, Adam R, et al
    HEPATIC EPITHELIOID HEMANGIO-ENDOTHELIOMA AND ADULT LIVER TRANSPLANTATION: PROPOSAL FOR A PROGNOSTIC SCORE BASED ON THE ANALYSIS OF THE ELTR-ELITA REGISTRY.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  38. SALAZAR J, Saxena V, Kahn JG, Roberts JP, et al
    Cost-Effectiveness of Direct-Acting Anti-viral Treatment in Hepatitis C-infected Liver Transplant Candidates with Compensated Cirrhosis and Hepatocellular Carcinoma.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  39. CROOME KP, Lee DD, Keaveny AP, Taner CB, et al
    Improving National Results in Liver Transplantation Using Grafts From Donation After Cardiac Death Donors.
    Transplantation. 2016;100:2640-2647.
    PubMed     Text format     Abstract available


  40. CARRILLO CF, Crespo G, de la Revilla J, Castells L, et al
    Successful continuation of HCV treatment following liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  41. MILLER CM, Quintini C, Dhawan A, Durand F, et al
    The International Liver Transplant Society (ILTS) Living Donor Liver Transplant Recipient Guideline.
    Transplantation. 2016.
    PubMed     Text format    


    November 2016
  42. BARBIER L, Cesaretti M, Dondero F, Cauchy F, et al
    Liver Transplantation With Older Donors: A Comparison With Younger Donors in a Context of Organ Shortage.
    Transplantation. 2016;100:2410-2415.
    PubMed     Text format     Abstract available


  43. ZAHR ELDEEN F, Roll GR, Derosas C, Rao R, et al
    Preoperative Thromboelastography as a Sensitive Tool Predicting Those at Risk of Developing Early Hepatic Artery Thrombosis After Adult Liver Transplantation.
    Transplantation. 2016;100:2382-2390.
    PubMed     Text format     Abstract available


  44. KRAWCZYK M, Grat M, Adam R, Polak WG, et al
    Liver Transplantation for Hepatic Trauma: A Study From the European Liver Transplant Registry.
    Transplantation. 2016;100:2372-2381.
    PubMed     Text format     Abstract available


    October 2016
  45. ROTELLAR F, Pardo F, Benito A, Zozaya G, et al
    Totally laparoscopic right hepatectomy for living donor liver transplantation. Analysis of a preliminary experience on 5 consecutive cases.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  46. NICASTRO E, Giovannozzi S, Stroppa P, Callegaro AP, et al
    Effectiveness of preemptive therapy for Cytomegalovirus disease in pediatric liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  47. IKEGAMI T, Shimagaki T, Kawasaki J, Yoshizumi T, et al
    Eversion technique to prevent biliary stricture after living donor liver transplantation in the universal minimal hilar dissection era.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  48. ALVAREZ-SOTOMAYOR D, Satorres C, Rodriguez-Medina B, Herrero I, et al
    Controlling Diabetes After Liver Transplantation: Room for Improvement.
    Transplantation. 2016;100:e66-e73.
    PubMed     Text format     Abstract available


  49. DEBETTE-GRATIEN M, Woillard JB, Picard N, Sebagh M, et al
    Influence of Donor and Recipient CYP3A4, CYP3A5, and ABCB1 Genotypes on Clinical Outcomes and Nephrotoxicity in Liver Transplant Recipients.
    Transplantation. 2016;100:2129-2137.
    PubMed     Text format     Abstract available


  50. CASSUTO E, Pageaux GP, Cantarovich D, Rostaing L, et al
    Adherence to and Acceptance of Once-Daily Tacrolimus After Kidney and Liver Transplant: Results From OSIRIS, a French Observational Study.
    Transplantation. 2016;100:2099-2106.
    PubMed     Text format     Abstract available


    September 2016
  51. CROOME KP, Lee DD, Keaveny AP, Burcin Taner C, et al
    IMPROVING NATIONAL RESULTS IN LIVER TRANSPLANTATION USING GRAFTS FROM DONATION AFTER CARDIAC DEATH DONORS.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  52. ELFEKI M, Abou Mrad R, Modaresi Esfeh J, Zein N, et al
    Sofosbuvir/Ledipasvir without Ribavirin Achieved High Sustained Virologic Response for Hepatitis C Recurrence after Liver Transplantation: Two-Center Experience.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    August 2016
  53. SCHLANSKY B, Naugler WE, Orloff SL, Enestvedt CK, et al
    Higher Mortality and Survival Benefit in Obese Patients Awaiting Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  54. POMPOSELLI JJ
    Hepatic Artery Thrombosis (HAT) After Liver Transplant: Not A Surgical Problem?
    Transplantation. 2016.
    PubMed     Text format    


  55. MOHKAM K, Fanget F, Darnis B, Harbaoui B, et al
    Use of systemic vasodilators for the management of Doppler ultrasound arterial abnormalities after orthotopic liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  56. MANDELL MS, Smith AR, Dew MA, Gordon DB, et al
    Early Postoperative Pain and its Predictors in the Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL).
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  57. DE CARLIS L, De Carlis R, Lauterio A, Di Sandro S, et al
    Sequential use of normothermic regional perfusion and hypothermic machine perfusion in donation after cardiac death liver transplantation with extended warm ischemia time.
    Transplantation. 2016.
    PubMed     Text format    


  58. DE SIMONE P, Fagiuoli S, Cescon M, De Carlis L, et al
    Use of Everolimus in Liver Transplantation: Recommendations From a Working Group.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  59. FURUICHI M, Fujiwara T, Fukuda A, Kasahara M, et al
    Fulminant hepatic failure as a risk factor for cytomegalovirus infection in children receiving preemptive therapy after living donor liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  60. CICALESE L, Shirafkan A, Jennings K, Zorzi D, et al
    Increased risk of death for patients on the waitlist for liver transplant residing at greater distance from specialized liver transplant centers in the USA.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  61. HART A, Schladt DP, Zeglin J, Pyke J, et al
    Predicting outcomes on the liver transplant waiting list in the United States: Accounting for large regional variation in organ availability and priority allocation points.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  62. HAMAGUCHI Y, Kaido T, Okumura S, Kobayashi A, et al
    Proposal of Muscle-MELD score, including muscularity, for prediction of mortality after living donor liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  63. MURALI AR, Chandra S, Stewart Z, Blazar BR, et al
    Graft versus Host Disease After Liver Transplantation in Adults: A Case series, Review of Literature, and an Approach to Management.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  64. SALIBA F, Rostaing L, Gugenheim J, Durand F, et al
    Corticosteroid-Sparing and Optimization of Mycophenolic Acid Exposure in Liver Transplant Recipients Receiving Mycophenolate Mofetil and Tacrolimus: A Randomized, Multicenter Study.
    Transplantation. 2016;100:1705-13.
    PubMed     Text format     Abstract available


    July 2016
  65. VIEHMAN JA, Clancy CJ, Clarke L, Shields R, et al
    Surgical site infections after liver transplantation: Emergence of multi-drug resistant bacteria and implications for prophylaxis and treatment strategies.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  66. PICHLER RH, Huskey J, Kowalewska J, Moiz A, et al
    Kidney Biopsies May Help Predict Renal Function following Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  67. GYOTEN K, Mizuno S, Kato H, Murata Y, et al
    A novel predictor of posttransplant portal hypertension in adult-to-adult living donor liver transplantation: increased estimated spleen/graft volume ratio.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  68. GOODRICH NP, Schaubel DE, Smith AR, Merion RM, et al
    National Assessment of Hospitalization Rates for Incident End Stage Renal Disease after Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  69. HAARER J, Riquelme P, Hoffmann P, Schnitzbauer A, et al
    Early Enrichment and Restitution of the Peripheral Blood Treg Pool Is Associated With Rejection-Free Stable Immunosuppression After Liver Transplantation.
    Transplantation. 2016;100:e39-40.
    PubMed     Text format    


  70. POMPOSELLI JJ, Goodrich NP, Emond JC, Humar A, et al
    Patterns of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: The A2ALL Experience.
    Transplantation. 2016;100:1490-9.
    PubMed     Text format     Abstract available


  71. KROWKA MJ, Fallon MB, Kawut SM, Fuhrmann V, et al
    International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension.
    Transplantation. 2016;100:1440-52.
    PubMed     Text format     Abstract available


  72. SULLIVAN T, Weinberg A, Rana M, Patel G, et al
    The Epidemiology and Clinical Features of Clostridium difficile Infection in Liver Transplant Recipients.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    June 2016
  73. FEIER FH, Seda-Neto J, da Fonseca EA, Candido HL, et al
    Analysis of Factors Associated With Biliary Complications in Children After Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  74. GEISSLER EK, Schnitzbauer AA, Schlitt HJ
    A Rebuttal Letter in Response to: Mammalian Target of Rapamycin Inhibitors Against Hepatocellular Carcinoma Recurrence After Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format    


  75. HSU CC, Chen CL, Wang CC, Lin CC, et al
    Combination of FDG-PET and UCSF Criteria for Predicting HCC Recurrence After Living Donor Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  76. CHOLONGITAS E
    Mammalian Target of Rapamycin Inhibitors Against Hepatocellular Carcinoma Recurrence After Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format    


  77. NARASIMHAN G, Safwan M, Kota V, Reddy MS, et al
    Donor Outcomes in Living Donor Liver Transplantation-Analysis of 275 Donors From a Single Centre in India.
    Transplantation. 2016;100:1251-6.
    PubMed     Text format     Abstract available


  78. EMOND JC
    Live Donor Liver Transplantation: An International Perspective.
    Transplantation. 2016;100:1182-3.
    PubMed     Text format    



  79. Russell W. Strong, FRCS (Eng), FRACS, FRACDS: Pioneering Live Donor Liver Transplantation.
    Transplantation. 2016;100:1177-9.
    PubMed     Text format    


  80. WERNER JM, Schlitt HJ
    Living Donor Liver Transplantation.
    Transplantation. 2016;100:1173-4.
    PubMed     Text format    


  81. SALVALAGGIO PR, Seda Neto J, Alves JA, Fonseca EA, et al
    Consensus, Dilemmas, and Challenges in Living Donor Liver Transplantation in Latin America.
    Transplantation. 2016;100:1161-4.
    PubMed     Text format     Abstract available


  82. WANG CW, Feng S, Covinsky KE, Hayssen H, et al
    A Comparison of Muscle Function, Mass, and Quality in Liver Transplant Candidates: Results From the Functional Assessment in Liver Transplantation Study.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    May 2016
  83. DEW MA, DiMartini AF, Ladner DP, Simpson MA, et al
    Psychosocial Outcomes 3 to 10 Years After Donation in the Adult to Adult Living Donor Liver Transplantation Cohort Study.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  84. TOMODA T, Kato H, Mizukawa S, Yabe S, et al
    Biliary Anastomotic Stricture After Adult Living Donor Liver Transplantation With Duct-to-Duct Reconstruction: Outcome After Endoscopic Treatment Including Rendezvous Procedure.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    April 2016
  85. KUBAL C, Mangus R, Fridell J, Saxena R, et al
    Optimization of Perioperative Conditions to Prevent Ischemic Cholangiopathy in Donation After Circulatory Death Donor Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  86. GHINOLFI D, De Simone P, Tincani G, Pezzati D, et al
    Beyond the Limit: Approaching Systematic Use of Nonagenarian Donors in Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format    


  87. BRITO-COSTA A, Pereira-da-Silva L, Papoila AL, Alves M, et al
    Factors Associated With Changes in Body Composition Shortly After Orthotopic Liver Transplantation: The Potential Influence of Immunosuppressive Agents.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  88. BRAUN HJ, Dodge JL, Roll GR, Freise CE, et al
    Impact of Graft Selection on Donor and Recipient Outcomes After Living Donor Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  89. MILLER CM, Durand F, Heimbach JK, Kim-Schluger L, et al
    The International Liver Transplant Society Guidelines on Living Liver Donation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  90. DE CARLIS L, Lauterio A, De Carlis R, Ferla F, et al
    Donation After Cardiac Death Liver Transplantation After More Than 20 Minutes of Circulatory Arrest and Normothermic Regional Perfusion.
    Transplantation. 2016;100:e21-2.
    PubMed     Text format    


  91. VITALONE MJ, Wei L, Fujiki M, Lau AH, et al
    Liver microRNA Profile of Induced Allograft Tolerance.
    Transplantation. 2016;100:781-90.
    PubMed     Text format     Abstract available


  92. MAS VR, Portilla D, Maluf DG
    Biomarkers of Transplant Tolerance: A Provisional Analysis for an Unmet Need.
    Transplantation. 2016;100:705-6.
    PubMed     Text format    


  93. REDDY MS, Shrivastav M, Kaliamoorthy I, Kota V, et al
    Safety of Live Liver Donation by Individuals With G6PD Deficiency: Initial Results and Comparative Study.
    Transplantation. 2016;100:814-8.
    PubMed     Text format     Abstract available


  94. LI AH, Lam NN, Naylor KL, Garg AX, et al
    Early Hospital Readmissions After Transplantation: Burden, Causes, and Consequences.
    Transplantation. 2016;100:713-8.
    PubMed     Text format     Abstract available


    March 2016
  95. DE SIMONE P, Romagnoli R, Tandoi F, Carrai P, et al
    Early Introduction of Subcutaneous Hepatitis B Immunoglobulin Following Liver Transplantation for Hepatitis B Virus Infection: A Prospective, Multicenter Study.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  96. CAO Y, Shahrestani S, Chew HC, Crawford M, et al
    Donation After Circulatory Death for Liver Transplantation: A Meta-Analysis on the Location of Life Support Withdrawal Affecting Outcomes.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  97. VANDEKERCKHOVE K, Coomans I, De Bruyne E, De Groote K, et al
    Evaluation of Exercise Performance, Cardiac Function, and Quality of Life in Children After Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  98. SEDA-NETO J, Antunes da Fonseca E, Pugliese R, Candido HL, et al
    Twenty Years of Experience in Pediatric Living Donor Liver Transplantation: Focus on Hepatic Artery Reconstruction, Complications and Outcomes.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  99. ADDOLORATO G, Bataller R, Burra P, DiMartini A, et al
    Liver Transplantation for Alcoholic Liver Disease.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  100. FAISAL N, Bilodeau M, Aljudaibi B, Hirsch G, et al
    Sofosbuvir-Based Antiviral Therapy Is Highly Effective In Recurrent Hepatitis C in Liver Transplant Recipients: Canadian Multicenter "Real-Life" Experience.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  101. MANAS D, Burnapp L, Andrews PA
    Summary of the British Transplantation Society UK Guidelines for Living Donor Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  102. FOSTER BJ, Dahhou M, Zhang X, Dharnidharka VR, et al
    High Risk of Liver Allograft Failure During Late Adolescence and Young Adulthood.
    Transplantation. 2016;100:577-84.
    PubMed     Text format     Abstract available


    February 2016
  103. RELA M, Reddy MS
    "Failure to Rescue" as a Novel Quality Metric in Pediatric Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format    


  104. CRAMM SL, Waits SA, Englesbe MJ, Bucuvalas JC, et al
    Failure to Rescue as a Quality Improvement Approach in Transplantation: A First Effort to Evaluate This Tool in Pediatric Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  105. LING Q, Xu X, Wang B, Li L, et al
    The Origin of New-Onset Diabetes After Liver Transplantation: Liver, Islets, or Gut?
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  106. WESTERKAMP AC, Karimian N, Matton AP, Mahboub P, et al
    Oxygenated Hypothermic Machine Perfusion After Static Cold Storage Improves Hepatobiliary Function of Extended Criteria Donor Livers.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  107. TOUSSAINT A, Weiss E, Khoy-Ear L, Janny S, et al
    Prognostic Value of Preoperative Brain Natriuretic Peptide Serum Levels in Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  108. WERNER JM, Vermehren J
    New HCV Therapies and Liver Transplantation.
    Transplantation. 2016;100:260-1.
    PubMed     Text format    


  109. SUHR OB, Larsson M, Ericzon BG, Wilczek HE, et al
    Survival After Transplantation in Patients With Mutations Other Than Val30Met: Extracts From the FAP World Transplant Registry.
    Transplantation. 2016;100:373-81.
    PubMed     Text format     Abstract available


    January 2016
  110. LIMAYE AP, La Rosa C, Longmate J, Diamond DJ, et al
    Plasma IL-10 Levels to Guide Antiviral Prophylaxis Prevention of Late-Onset Cytomegalovirus Disease, in High Risk Solid Kidney and Liver Transplant Recipients.
    Transplantation. 2016;100:210-6.
    PubMed     Text format     Abstract available


  111. POMFRET EA
    Killing Two Birds With One Stone: Antineoplastic Immunosuppression.
    Transplantation. 2016;100:14-5.
    PubMed     Text format    


  112. LEUVENINK HG
    Warming Up--Not Only Essential for Athletes?
    Transplantation. 2016;100:10-1.
    PubMed     Text format    


  113. HOYER DP, Mathe Z, Gallinat A, Canbay AC, et al
    Controlled Oxygenated Rewarming of Cold Stored Livers Prior to Transplantation: First Clinical Application of a New Concept.
    Transplantation. 2016;100:147-52.
    PubMed     Text format     Abstract available


  114. VIJGEN S, Wyss C, Meylan P, Bisig B, et al
    Fatal Outcome of Multiple Clinical Presentations of Human Herpesvirus 8-related Disease After Solid Organ Transplantation.
    Transplantation. 2016;100:134-40.
    PubMed     Text format     Abstract available


    December 2015
  115. DU H, Sheng M, Wu L, Zhang Y, et al
    Hydrogen-Rich Saline Attenuates Acute Kidney Injury After Liver Transplantation via Activating p53-Mediated Autophagy.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  116. TANIMINE N, Tanaka Y, Abe T, Piao J, et al
    Functional Behavior of NKp46-Positive Intrahepatic Natural Killer Cells Against Hepatitis C Virus Reinfection After Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  117. ABERG F, Nordin A, Toivonen L, Isoniemi H, et al
    Early Predictors of Long-term Outcomes of HCV-Negative Liver Transplant Recipients Having Survived the First Postoperative Year.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  118. DOYCHEVA I, Leise MD, Watt KD
    The Intestinal Microbiome and the Liver Transplant Recipient: What We Know and What We Need to Know.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  119. GLOVER TE, Watson CJ, Gibbs P, Bradley JA, et al
    Conversion From Calcineurin to Mammalian Target of Rapamycin Inhibitors in Liver Transplantation: A Meta-Analysis of Randomized Controlled Trials.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  120. THORSEN T, Aandahl EM, Bennet W, Olausson M, et al
    Transplantation With Livers From Deceased Donors Older Than 75 Years.
    Transplantation. 2015;99:2534-42.
    PubMed     Text format     Abstract available


    November 2015
  121. MAS V, Archer KJ, Maluf D
    The High-Risk Age Window After Pediatric Liver Transplantation: Modeling Allograft Loss Using Mathematical Tools.
    Transplantation. 2015.
    PubMed     Text format    


  122. OLMEDILLA L, Lisbona CJ, Perez-Pena JM, Lopez-Baena JA, et al
    Early Measurement of Indocyanine Green Clearance Accurately Predicts Short-Term Outcomes After Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  123. GEISSLER EK, Schnitzbauer AA, Zulke C, Lamby PE, et al
    Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  124. ISMAIL SY, Duerinckx N, van der Knoop MM, Timmerman L, et al
    Toward a Conceptualization of the Content of Psychosocial Screening in Living Organ Donors: An Ethical Legal Psychological Aspects of Transplantation Consensus.
    Transplantation. 2015;99:2413-21.
    PubMed     Text format     Abstract available


  125. IGARASHI Y, Onoe T, Ohdan H
    The Role of Liver Sinusoidal Endothelial Cells in Induction of Carbohydrate Reactive B Cells Tolerance Through the Programmed Death 1/Programmed Death Ligand 1 Pathway.
    Transplantation. 2015;99:2325-36.
    PubMed     Text format     Abstract available


  126. MARIANTE-NETO G, Brandao AB
    Model for End-Stage Liver Disease: Is Sex-Based Creatinine Correction a Viable Strategy for Black Females?
    Transplantation. 2015;99:2337-40.
    PubMed     Text format     Abstract available


  127. NOBEL YR, Goldberg DS
    Variable Use of Model for End-Stage Liver Disease Exception Points in Patients With Neuroendocrine Tumors Metastatic to the Liver and Its Impact on Patient Outcomes.
    Transplantation. 2015;99:2341-6.
    PubMed     Text format     Abstract available


    October 2015
  128. ROSSI AP, Vella JP
    Acute Kidney Disease After Liver and Heart Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  129. SINGAL AK, Hasanin M, Kaif M, Wiesner R, et al
    Nonalcoholic Steatohepatitis is the Most Rapidly Growing Indication for Simultaneous Liver Kidney Transplantation in the United States.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  130. EDMUNDS C, Ekong UD
    Autoimmune Liver Disease Post Liver Transplantation-A Summary and Proposed Areas for Future Research.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    September 2015
  131. CASTON JJ, Castells L, Varo E, Gomez MA, et al
    Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  132. CHOI Y, Yi NJ, Ko JS, Moon JS, et al
    Reappraisal of the Role of Portacaval Shunting in the Growth of Patients With Glycogen Storage Disease Type I in the Era of Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  133. LEE J, Yoo YJ, Lee JM, Park YJ, et al
    Sevoflurane Versus Desflurane on the Incidence of Postreperfusion Syndrome During Living Donor Liver Transplantation: A Randomized Controlled Trial.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  134. UEDA Y, Uemoto S
    Interferon-Free Therapy for Hepatitis C in Liver Transplant Recipients.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  135. PAPE E, Scala-Bertola J, Petitpain N, Jouzeau JY, et al
    Management of Tacrolimus-Telaprevir Drug-Drug Interaction in a Liver Transplant Patient With Hepatitis C Virus: Practical Considerations.
    Transplantation. 2015;99:e163-e164.
    PubMed     Text format    


  136. GIACOMONI A, Concone G, Di Sandro S, Lauterio A, et al
    Hepatocellular Carcinoma Progression While on Waiting List for Liver Transplantation.
    Transplantation. 2015;99:e155-e156.
    PubMed     Text format    


  137. MANGUS RS, Fridell JA, Kubal CA, Loeffler AL, et al
    Worse Long-term Patient Survival and Higher Cancer Rates in Liver Transplant Recipients With a History of Smoking.
    Transplantation. 2015;99:1862-1868.
    PubMed     Text format     Abstract available


  138. MANGUS RS, Lutz AJ, Fridell JA, Kubal CA, et al
    Minimal Improvement in Glomerular Filtration Rate in the First Year After Liver Transplantation.
    Transplantation. 2015;99:1855-1861.
    PubMed     Text format     Abstract available


  139. ERICZON BG, Wilczek HE, Larsson M, Wijayatunga P, et al
    Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative?
    Transplantation. 2015;99:1847-1854.
    PubMed     Text format     Abstract available


  140. MEHROTRA S, Kilambi V, Gilroy R, Ladner DP, et al
    The Authors' Reply.
    Transplantation. 2015;99:e160-1.
    PubMed     Text format    


  141. GENTRY SE, Segev DL, Kasiske BL, Mulligan DC, et al
    Robust Models Support Redistricting Liver Allocation to Reduce Geographic Disparity.
    Transplantation. 2015;99:e159-60.
    PubMed     Text format    


  142. PARAJULI S, Foley D, Djamali A, Mandelbrot D, et al
    Renal Function and Transplantation in Liver Disease.
    Transplantation. 2015;99:1756-64.
    PubMed     Text format     Abstract available


  143. IACOB S, Cicinnati VR, Lindemann M, Heinemann FM, et al
    Donor-Specific Anti-HLA Antibodies and Endothelial C4d Deposition-Association With Chronic Liver Allograft Failure.
    Transplantation. 2015;99:1869-75.
    PubMed     Text format     Abstract available


    August 2015
  144. GEHRAU RC, Mas VR, Dumur CI, Suh JL, et al
    Donor Hepatic Steatosis Induce Exacerbated Ischemia-Reperfusion Injury Through Activation of Innate Immune Response Molecular Pathways.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  145. MCELROY LM, Schmidt KA, Richards CT, Lapin B, et al
    Early Postoperative Emergency Department Care of Abdominal Transplant Recipients.
    Transplantation. 2015;99:1652-7.
    PubMed     Text format     Abstract available


  146. BECKER BN, Becker YT
    Evaluating the Emergency Department as a Site of Transplant Care.
    Transplantation. 2015;99:1549-50.
    PubMed     Text format    


  147. RAVAIOLI M, Neri F, Lazzarotto T, Bertuzzo VR, et al
    Immunosuppression Modifications Based on an Immune Response Assay: Results of a Randomized, Controlled Trial.
    Transplantation. 2015;99:1625-32.
    PubMed     Text format     Abstract available


    July 2015
  148. LOCKE JE, Durand C, Reed RD, MacLennan PA, et al
    Long-Term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  149. PATERNO F, Wima K, Hoehn RS, Cuffy MC, et al
    Use of Elderly Allografts in Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  150. FISCHER L, Saliba F, Kaiser GM, De Carlis L, et al
    Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study.
    Transplantation. 2015;99:1455-62.
    PubMed     Text format     Abstract available


  151. SEMER NB
    Awaiting Liver Transplantation.
    Transplantation. 2015;99:e48.
    PubMed     Text format    


  152. CHAPMAN JR, Pomfret EA
    President's Address: International Liver Transplantation Society.
    Transplantation. 2015;99:1301.
    PubMed     Text format    


    June 2015
  153. SINGH N, Winston DJ, Limaye AP, Pelletier S, et al
    Performance Characteristics of Galactomannan and beta-d-Glucan in High-Risk Liver Transplant Recipients.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  154. GHABRIL M, Agarwal S, Lacerda M, Chalasani N, et al
    Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors and Outcomes for Portal Vein Thrombosis in Waitlisted Patients.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  155. SHAPIRO AM
    Donor-Specific Antibody in Pediatric Liver Transplantation-Identifying a Tree by its Fruit.
    Transplantation. 2015.
    PubMed     Text format    


  156. ROCHE B, Roque-Afonso AM, Nevens F, Samuel D, et al
    Rational Basis for Optimizing Short and Long-Term Hepatitis B Virus Prophylaxis Post Liver Transplantation. Role of Hepatitis B Immune Globulin.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  157. WOZNIAK LJ, Hickey MJ, Venick RS, Vargas JH, et al
    Donor-Specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  158. ALHAMAD T, Uemura T, Lehman E, Spatz C, et al
    Utilization of donors after cardiac death organs for simultaneous liver and kidney transplantation.
    Transplantation. 2015;99:e40-1.
    PubMed     Text format    


  159. WADEI HM, Taner CB
    Simultaneous liver-kidney transplantation from donation after cardiac death donors: is there a better way to use these organs?
    Transplantation. 2015;99:e39.
    PubMed     Text format    


  160. ASCHER NL
    Nancy L. Ascher, MD, PhD: Professor and Chair, Department of Surgery, UCSF; Past-President, ASTS; President-elect, The Transplantation Society.
    Transplantation. 2015;99:1106.
    PubMed     Text format    


  161. GOLDIN MM, Khubutia MSh, Evseev AK, Goldin MM, et al
    Noninvasive diagnosis of dysfunctions in patients after organ transplantation by monitoring the redox potential of blood serum.
    Transplantation. 2015;99:1288-92.
    PubMed     Text format     Abstract available


  162. WU G, Cruz RJ
    Liver inclusion improves outcomes of intestinal retransplantation in adults.
    Transplantation. 2015;99:1265-72.
    PubMed     Text format     Abstract available


    May 2015
  163. HAYASHI K, Uchida H, Takaoka C, Izawa Y, et al
    Discrepancy in Psychological Attitudes Toward Living Donor Liver Transplantation Between Recipients and Donors.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  164. SCHNITZBAUER AA, Sothmann J, Baier L, Bein T, et al
    Calcineurin Inhibitor Free De Novo Immunosuppression in Liver Transplant Recipients With Pretransplant Renal Impairment: Results of a Pilot Study (PATRON07).
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  165. CHENG Q, He SQ, Gao D, Lei B, et al
    Early Application of Auxiliary Partial Orthotopic Liver Transplantation in Murine Model of Wilson Disease.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  166. GOLSE N, Bucur PO, Faitot F, Bekheit M, et al
    Spontaneous Splenorenal Shunt in Liver Transplantation: Results of Left Renal Vein Ligation Versus Renoportal Anastomosis.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  167. LONGENECKER JC, Estrella MM, Segev DL, Atta MG, et al
    Patterns of Kidney Function Before and After Orthotopic Liver Transplant: Associations With Length of Hospital Stay, Progression to End-Stage Renal Disease, and Mortality.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  168. MOROSO V, van Cranenbroek B, Mancham S, Sideras K, et al
    Prominent HLA-G Expression in Liver Disease But Not After Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  169. LACERDA PC, Moreira L, Vitorino R, Costa PP, et al
    Use of MALDI-TOF Mass Spectrometry to Assay the Transthyretin V30M Mutation in Serum From a Liver Transplant Donor: A Case Report.
    Transplantation. 2015;99:e33-4.
    PubMed     Text format    


    April 2015
  170. LEE SD, Kim SH, Kim SK, Kim YK, et al
    Clinical Impact of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  171. SALEM R, Vouche M, Baker T, Herrero JI, et al
    Pretransplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein Thrombosis.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  172. RICCA L, Lemoine A, Cauchy F, Hamelin J, et al
    Ischemic Postconditioning of the Liver Graft in Adult Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  173. BREUER C, Oh J, Nolkemper D, Achilles EG, et al
    Successful detoxification and liver transplantation in a severe poisoning with a chemical wood preservative containing chromium, copper, and arsenic.
    Transplantation. 2015;99:e29-30.
    PubMed     Text format    


  174. CRUZ RJ JR
    A facilitated method for hepatic vein blood: sampling during liver transplantation.
    Transplantation. 2015;99:e25-6.
    PubMed     Text format    


    March 2015
  175. SINGH N, Sifri CD, Silveira FP, Miller R, et al
    Cryptococcosis in Patients With Cirrhosis of the Liver and Posttransplant Outcomes.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  176. BECK-SCHIMMER B, Bonvini JM, Schadde E, Dutkowski P, et al
    Conditioning With Sevoflurane in Liver Transplantation: Results of a Multicenter Randomized Controlled Trial.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  177. SCHIEFER J, Lebherz-Eichinger D, Erdoes G, Berlakovich G, et al
    Alterations of Endothelial Glycocalyx During Orthotopic Liver Transplantation in Patients With End-Stage Liver Disease.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  178. HOON KIM S, Duke Lee S, Kyu-Kim Y, Park SJ, et al
    Living Donors Ages 60 or Older in Right Lobe Living Donor Liver Transplantation.
    Transplantation. 2015;99:e16-e17.
    PubMed     Text format    


  179. RANA A, Kaplan B, Riaz IB, Porubsky M, et al
    Geographic inequities in liver allograft supply and demand: does it affect patient outcomes?
    Transplantation. 2015;99:515-20.
    PubMed     Text format     Abstract available


  180. CEULEMANS LJ, De Hertogh G, Van Cromphaut S, Vermeire S, et al
    Nonsteroidal anti-inflammatory drug-induced intestinal graft loss 12 years after transplantation.
    Transplantation. 2015;99:e18-9.
    PubMed     Text format    


  181. VERGHESE PS, Schmeling DO, Knight JA, Matas AJ, et al
    The impact of donor viral replication at transplant on recipient infections posttransplant: a prospective study.
    Transplantation. 2015;99:602-8.
    PubMed     Text format     Abstract available


    February 2015
  182. MANCIA C, Loustaud-Ratti V, Carrier P, Naudet F, et al
    Controlled Attenuation Parameter and Liver Stiffness Measurements for Steatosis Assessment in the Liver Transplant of Brain Dead Donors.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  183. VERNA EC, Saxena V, Burton JR Jr, O'Leary JG, et al
    Telaprevir- and Boceprevir-Based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter Study.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  184. BURGIO MD, Ronot M, Fuks D, Dondero F, et al
    Follow-up Imaging After Liver Transplantation Should Take Into Consideration Primary Hepatocellular Carcinoma Characteristics.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  185. ZHOU Y, Yang X, Zhang H, Jiang J, et al
    The Roles of T Helper Type 17/Regulatory T Cells in Acute Rejection After Liver Transplantation in Rats.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  186. RAHMAN W, Tu T, Budzinska M, Huang P, et al
    Analysis of Post-Liver Transplant Hepatitis C Virus Recurrence Using Serial Cluster of differentiation Antibody Microarrays.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  187. GRABHORN E, Binder TM, Obrecht D, Brinkert F, et al
    Long-Term Clinical Relevance of De Novo Donor-Specific Antibodies After Pediatric Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  188. KOIKE K, Takaki A, Yagi T, Iwasaki Y, et al
    Enhancement of Programmed Death Ligand 2 on Hepatitis C Virus Infected Hepatocytes by Calcineurin Inhibitors.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  189. ABDO A
    Liver transplantation in latin america.
    Transplantation. 2015;99:e10.
    PubMed     Text format    


  190. MEHROTRA S, Kilambi V, Gilroy R, Ladner DP, et al
    Modeling the allocation system: principles for robust design before restructuring.
    Transplantation. 2015;99:278-81.
    PubMed     Text format     Abstract available


    January 2015
  191. TAN HK, Marquez M, Wong F, Renner EL, et al
    Pretransplant Type 2 Hepatorenal Syndrome Is Associated With Persistently Impaired Renal Function After Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  192. ALLEN AM, Kim WR, Larson JJ, Colby C, et al
    Serum Cystatin C as an Indicator of Renal Function and Mortality in Liver Transplant Recipients.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  193. ZITTA S, Schaffellner S, Gutschi J, Meinitzer A, et al
    The Effect of Mammalian Target of Rapamycin Versus Calcineurin Inhibitor-Based Immunosuppression on Measured Versus Estimated Glomerular Filtration Rate After Orthotopic Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  194. OEZCELIK A, Dayangac M, Guler N, Yaprak O, et al
    Living Donor Liver Transplantation in Patients 70 Years or Older.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  195. DERCK JE, Thelen AE, Cron DC, Friedman JF, et al
    Quality of Life in Liver Transplant Candidates: Frailty Is a Better Indicator Than Severity of Liver Disease.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  196. DEBETTE-GRATIEN M, Tabouret T, Antonini MT, Dalmay F, et al
    Personalized adapted physical activity before liver transplantation: acceptability and results.
    Transplantation. 2015;99:145-50.
    PubMed     Text format     Abstract available


  197. ASHOKKUMAR C, Sun Q, Ningappa M, Higgs BW, et al
    Antithymocyte globulin facilitates alloreactive T-cell apoptosis by means of caspase-3: potential implications for monitoring rejection-free outcomes.
    Transplantation. 2015;99:164-70.
    PubMed     Text format     Abstract available


    December 2014
  198. DONNADIEU B, Amouyal F, Hoffart L, Matonti F, et al
    Central Retinal Vein Occlusion-Associated Tacrolimus After Liver Transplantation.
    Transplantation. 2014;98:e94-e95.
    PubMed     Text format    


  199. RAICHLIN E, Um JY, Duncan KF, Dumitru I, et al
    Combined Heart and Liver Transplantation Against Positive Cross-Match for Patient With Hypoplastic Left Heart Syndrome.
    Transplantation. 2014;98:e100-e102.
    PubMed     Text format    


  200. GEBHARDT S, Jara M, Malinowski M, Seehofer D, et al
    Risk Factors of Metabolic Disorders After Liver Transplantation: An Analysis of Data From Fasted Patients.
    Transplantation. 2014.
    PubMed     Text format     Abstract available


  201. YOO MC, Vanatta JM, Modanlou KA, Campos L, et al
    Steroid-Free Liver Transplantation Using Rabbit Antithymocyte Globulin Induction in 500 Consecutive Patients.
    Transplantation. 2014.
    PubMed     Text format     Abstract available


    November 2014
  202. OHE H, Uchida Y, Yoshizawa A, Hirao H, et al
    Association of anti-human leukocyte antigen and anti-angiotensin II type 1 receptor antibodies with liver allograft fibrosis after immunosuppression withdrawal.
    Transplantation. 2014;98:1105-11.
    PubMed     Text format     Abstract available


  203. CRIVELLIN C, Cagnin A, Manara R, Boccagni P, et al
    Risk Factors for Central Pontine and Extrapontine Myelinolysis After Liver Transplantation: A Single Center Study.
    Transplantation. 2014.
    PubMed     Text format     Abstract available


  204. IGUCHI T, Shirabe K, Aishima S, Wang H, et al
    New Pathologic Stratification of Microvascular Invasion in Hepatocellular Carcinoma: Predicting Prognosis After Living-Donor Liver Transplantation.
    Transplantation. 2014.
    PubMed     Text format     Abstract available


    October 2014
  205. BOUDECHICHE L, Tranchart H, Branchereau S, Davit-Spraul A, et al
    Improvement of Hepatocyte Transplantation Efficiency in the mdr2-/- Mouse Model by Glyceryl Trinitrate.
    Transplantation. 2014.
    PubMed     Text format     Abstract available


  206. JAIN A, Constantinescu S, Maloo M, Mukerji AN, et al
    Delayed introduction of tacrolimus postliver transplant with intravenous mycophenolate mofetil preserves renal function without incurring rejection.
    Transplantation. 2014;98:e68-70.
    PubMed     Text format    


  207. FRIEDEWALD JJ, Salvalaggio PR
    The Jury Is Out on the Utilization of Donors After Cardiac Death for Simultaneous Liver and Kidney Transplantation.
    Transplantation. 2014.
    PubMed     Text format    


    September 2014
  208. GONZALEZ-ESTRADA A, Fernandez J
    Novel valganciclovir desensitization protocol.
    Transplantation. 2014;98:e50-1.
    PubMed     Text format    


  209. KANZOW P, Kollmar O, Schutz E, Oellerich M, et al
    Graft-derived cell-free DNA as an early organ integrity biomarker after transplantation of a marginal HELLP syndrome donor liver.
    Transplantation. 2014;98:e43-5.
    PubMed     Text format    


  210. GIANNELLA M, Ercolani G, Cristini F, Morelli M, et al
    High-Dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation: A Prospective Phase II Trial.
    Transplantation. 2014.
    PubMed     Text format     Abstract available


    August 2014
  211. ALHAMAD T, Spatz C, Tadahiro U, Lehman E, et al
    The Outcomes of Simultaneous Liver and Kidney Transplantation Using Donation After Cardiac Death Organs.
    Transplantation. 2014.
    PubMed     Text format     Abstract available


  212. CHANG Y, Gallon L, Shetty K, Chang Y, et al
    Simulation Modeling of the Impact of Proposed New Simultaneous Liver and Kidney Transplantation Policies.
    Transplantation. 2014.
    PubMed     Text format     Abstract available


    May 2014
  213. STERN M, Hirsch H, Cusini A, van Delden C, et al
    Cytomegalovirus Serology and Replication Remain Associated With Solid Organ Graft Rejection and Graft Loss in the Era of Prophylactic Treatment.
    Transplantation. 2014.
    PubMed     Text format     Abstract available


  214. SIDHU A, Verma G, Humar A, Kumar D, et al
    Outcome of Latent Tuberculosis Infection in Solid Organ Transplant Recipients Over a 10-Year Period.
    Transplantation. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: